日本市场个股详情

4884 Kringle Pharma

添加自选
  • 1041
  • -11-1.05%
延时20分钟行情已收盘 01/28 15:30 (东京)
71.16亿总市值-8.81市盈率(静)

关于Kringle Pharma公司

Kringle Pharma Inc从事HGF(肝细胞生长因子)蛋白的研究和开发,该蛋白是治疗难治性疾病的药物。

公司介绍

公司代码4884
公司名称Kringle Pharma
成立日期2001-12-21
所属市场东证Growth
年结日09-30
公司地址7-7-15 Saitoasagi 207 Saito Bio-Incubator
邮编567-0085
电话072-641-8739

董事高管

  • 姓名
  • 职务
  • 年薪
  • Yoshikazu Adachi
  • President and Chief Executive Officer
  • --
  • Koichi Murakami
  • Director and General Manager of Corporate Administration
  • --
  • Daima Hayata
  • Director, General Manager of Pharmaceutical Development Department and General Manager of Pharmaceutical Affairs Department
  • --
  • Yoshiyuki Kayano
  • Director, General Manager of Reliability Assurance Department
  • --
  • Tomoho Masataku
  • Director
  • --
  • Masato Fukui
  • Independent Director
  • --
  • Koichiro Yoshino
  • Independent Director
  • --